OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.85
Data as of 12:40pm ET
 0.00 / 0.00%
Today’s Change
2.76
Today|||52-Week Range
14.25
-65.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$60.2M

Company Description

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company. It develops and commercializes new cancer therapies that address treatment resistance in cancer patients. The company has three product candidates in development: Custirsen, OGX-427 and OGX-225. OncoGenex Pharmaceuticals was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.

Contact Information

OncoGenex Pharmaceuticals, Inc.
1522-217th Place SE
Bothell Washington 98021
P:(425) 686-1500
Investor Relations:
(425) 686-1535

Employees

Shareholders

Mutual fund holders8.43%
Individual stakeholders6.26%
Other institutional42.57%

Top Executives

Scott Daniel CormackPresident, CEO, Secretary, Treasurer & Director
John A. BencichChief Financial Officer & Vice President
Patricia S. StewartVice President-Clinical Development
Cindy A. JacobsChief Medical Officer & Executive Vice President
Jaime WelchVP-Marketing & Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.